The following highlights key, current information for immunization providers on COVID-19 vaccine. The evidence on COVID-19 disease and vaccines is evolving. Evidence from clinical trial data is limited due to limitations in the size and duration of follow-up of trial populations; however, studies are ongoing. NACI will continue to monitor the data and update its recommendations as needed. Please refer to the remainder of the Statement for details.
Of note, Pfizer BioNTech COVID-19 and Moderna COVID-19 vaccine are the only two vaccines currently authorized in Canada, as of January 12th 2021.
- NITAG Recommendation